BQST — Bioquest Income Statement
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap
- $29.90m
- $30.06m
Annual income statement for Bioquest, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2013 April 30th | 2014 April 30th | 2021 April 30th | 2022 April 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | ||||
| Gross Profit | — | — | -1.41 | — |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | 0.008 | 0.124 | 2.2 | 0.818 |
| Operating Profit | -0.008 | -0.124 | -2.2 | -0.818 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.008 | -0.488 | -2.32 | -0.821 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.008 | -0.488 | -2.32 | -0.821 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.008 | -0.488 | -2.32 | -0.821 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -0.008 | -0.488 | -2.32 | -0.821 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.032 | -1.8 | -0.281 | -0.081 |
| Dividends per Share |